Venetoclax Plus Rituximab can Achieve Durable Treatment-Free Remission in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Autor: Choi, Michael, Brander, Danielle, Roberts, Andrew W., Seymour, John F., Kipps, Thomas J., Barrientos, Jacqueline C., Davids, Matthew S., Anderson, Mary Ann, Tam, Constantine, Prine, Betty, Cornejo, Carmen, Zhu, Ming, Lash, Leanne, Kim, Su Young, Ma, Shuo
Zdroj: In Clinical Lymphoma Myeloma and Leukemia September 2016 16 Supplement 2:S50-S51
Databáze: ScienceDirect
Externí odkaz: